Search PDMR transactions

Notifier
Name of person with notification obligation
Nicklas Westerholm
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Nicklas Westerholm
Position
Chief Executive Officer (CEO)/Managing Directory
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
Egetis Therapeutics AB (publ)
Issuer´s LEI code
549300RZCKGWRUBPMY22
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Share Egetis Therapeutics AB SE0003815604 Acquisition 529,761 Quantity 0.00 SEK 11/05/2026 Outside a trading venue
Share Egetis Therapeutics AB SE0003815604 Disposal 286,071 Quantity 6.50 SEK 13/05/2026 Outside a trading venue
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
Egetis Therapeutics AB SE0003815604 Acquisition 11/05/2026 Outside a trading venue 529,761 (Quantity) 0.00 SEK
Egetis Therapeutics AB SE0003815604 Disposal 13/05/2026 Outside a trading venue 286,071 (Quantity) 6.50 SEK
<< Back